Multiple Sclerosis

New research published in Nature has found several drugs could lead to new treatment options for multiple sclerosis (MS), including two drugs that effectively treat MS at the source, in vivo. When administered at the peak of disease, these two drugs showed a striking reversal of disease severity.

Vittorio Gallo, Ph.D., professor of pediatrics, was featured in Medical Daily for his research finding a “potentially novel therapeutic target” to reduce the rate of deterioration and to promote growth of brain cells damaged by multiple sclerosis (MS).

Vittorio Gallo, Ph.D., director of the Center for Neuroscience Research at Children’s National Health System and professor of pediatrics, and other researchers have found a “potentially novel therapeutic target” to reduce the rate of deterioration and to promote growth of brain cells damaged by…